The global Liquid Biopsy For Cancer Diagnostics market size was valued at USD 3708 million in 2022 and is forecast to a readjusted size of USD 8129.3 million by 2029 with a CAGR of 11.9% during review period.
Liquid biopsy for cancer diagnostics refers to a non-invasive medical test that analyzes blood or other body fluids to detect and analyze genetic alterations, proteins, or other molecules associated with cancer. Unlike traditional biopsies, which involve the surgical removal of a tissue sample, liquid biopsies provide a less invasive and more accessible method for detecting and monitoring cancer.
Researchers and developers continue to explore and expand the clinical utility of liquid biopsy. This includes investigating its application in various cancer types, different stages of cancer, and for monitoring treatment response and minimal residual disease.
Report includes an overview of the development of the Liquid Biopsy For Cancer Diagnostics industry chain, the market status of Hospital (Blood Test, Urine Test), Diagnostic Center (Blood Test, Urine Test), and key enterprises in developed and developing market, and analyzed the cutting-edge technology, patent, hot applications and market trends of Liquid Biopsy For Cancer Diagnostics.
Regionally, the report analyzes the Liquid Biopsy For Cancer Diagnostics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Liquid Biopsy For Cancer Diagnostics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Liquid Biopsy For Cancer Diagnostics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Liquid Biopsy For Cancer Diagnostics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Blood Test, Urine Test).
Industry Analysis: Report analyze the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Liquid Biopsy For Cancer Diagnostics market.
Regional Analysis: The report involves examining the Liquid Biopsy For Cancer Diagnostics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behavior to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Liquid Biopsy For Cancer Diagnostics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Liquid Biopsy For Cancer Diagnostics:
Company Analysis: Report covers individual Liquid Biopsy For Cancer Diagnostics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behavior, preferences, and attitudes towards Liquid Biopsy For Cancer Diagnostics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospital, Diagnostic Center).
Technology Analysis: Report covers specific technologies relevant to Liquid Biopsy For Cancer Diagnostics. It assesses the current state, advancements, and potential future developments in Liquid Biopsy For Cancer Diagnostics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Liquid Biopsy For Cancer Diagnostics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
F. Hoffman La Roche Ltd.
Thermo Fisher Scientific Inc.
Agilent Technologies Inc.
Illumina Inc.
The Menarini Group
Bio-Rad Laboratories Inc.
QIAGEN Inc.
Exact Sciences Corporation
Bio-Techne Corporation
ArcherDX Inc.
Neogenomics Laboratories Inc.
Guardant Health Inc.
Myriad Genetics Inc.
Foundation Medicine Inc.
Amoy Diagnostics Co. Ltd.
Biocartis Group NV
Blood Test
Urine Test
Saliva Test
Hospital
Diagnostic Center
Others
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Liquid Biopsy For Cancer Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Liquid Biopsy For Cancer Diagnostics, with revenue, gross margin and global market share of Liquid Biopsy For Cancer Diagnostics from 2018 to 2023.
Chapter 3, the Liquid Biopsy For Cancer Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Liquid Biopsy For Cancer Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Liquid Biopsy For Cancer Diagnostics.
Chapter 13, to describe Liquid Biopsy For Cancer Diagnostics research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Liquid Biopsy For Cancer Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Liquid Biopsy For Cancer Diagnostics by Type
1.3.1 Overview: Global Liquid Biopsy For Cancer Diagnostics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Type in 2022
1.3.3 Blood Test
1.3.4 Urine Test
1.3.5 Saliva Test
1.4 Global Liquid Biopsy For Cancer Diagnostics Market by Application
1.4.1 Overview: Global Liquid Biopsy For Cancer Diagnostics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Diagnostic Center
1.4.4 Others
1.5 Global Liquid Biopsy For Cancer Diagnostics Market Size & Forecast
1.6 Global Liquid Biopsy For Cancer Diagnostics Market Size and Forecast by Region
1.6.1 Global Liquid Biopsy For Cancer Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Liquid Biopsy For Cancer Diagnostics Market Size by Region, (2018-2029)
1.6.3 North America Liquid Biopsy For Cancer Diagnostics Market Size and Prospect (2018-2029)
1.6.4 Europe Liquid Biopsy For Cancer Diagnostics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size and Prospect (2018-2029)
1.6.6 South America Liquid Biopsy For Cancer Diagnostics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Liquid Biopsy For Cancer Diagnostics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 F. Hoffman La Roche Ltd.
2.1.1 F. Hoffman La Roche Ltd. Details
2.1.2 F. Hoffman La Roche Ltd. Major Business
2.1.3 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.1.4 F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 F. Hoffman La Roche Ltd. Recent Developments and Future Plans
2.2 Thermo Fisher Scientific Inc.
2.2.1 Thermo Fisher Scientific Inc. Details
2.2.2 Thermo Fisher Scientific Inc. Major Business
2.2.3 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.2.4 Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Thermo Fisher Scientific Inc. Recent Developments and Future Plans
2.3 Agilent Technologies Inc.
2.3.1 Agilent Technologies Inc. Details
2.3.2 Agilent Technologies Inc. Major Business
2.3.3 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.3.4 Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Agilent Technologies Inc. Recent Developments and Future Plans
2.4 Illumina Inc.
2.4.1 Illumina Inc. Details
2.4.2 Illumina Inc. Major Business
2.4.3 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.4.4 Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Illumina Inc. Recent Developments and Future Plans
2.5 The Menarini Group
2.5.1 The Menarini Group Details
2.5.2 The Menarini Group Major Business
2.5.3 The Menarini Group Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.5.4 The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 The Menarini Group Recent Developments and Future Plans
2.6 Bio-Rad Laboratories Inc.
2.6.1 Bio-Rad Laboratories Inc. Details
2.6.2 Bio-Rad Laboratories Inc. Major Business
2.6.3 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.6.4 Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Bio-Rad Laboratories Inc. Recent Developments and Future Plans
2.7 QIAGEN Inc.
2.7.1 QIAGEN Inc. Details
2.7.2 QIAGEN Inc. Major Business
2.7.3 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.7.4 QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 QIAGEN Inc. Recent Developments and Future Plans
2.8 Exact Sciences Corporation
2.8.1 Exact Sciences Corporation Details
2.8.2 Exact Sciences Corporation Major Business
2.8.3 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.8.4 Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Exact Sciences Corporation Recent Developments and Future Plans
2.9 Bio-Techne Corporation
2.9.1 Bio-Techne Corporation Details
2.9.2 Bio-Techne Corporation Major Business
2.9.3 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.9.4 Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Bio-Techne Corporation Recent Developments and Future Plans
2.10 ArcherDX Inc.
2.10.1 ArcherDX Inc. Details
2.10.2 ArcherDX Inc. Major Business
2.10.3 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.10.4 ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 ArcherDX Inc. Recent Developments and Future Plans
2.11 Neogenomics Laboratories Inc.
2.11.1 Neogenomics Laboratories Inc. Details
2.11.2 Neogenomics Laboratories Inc. Major Business
2.11.3 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.11.4 Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Neogenomics Laboratories Inc. Recent Developments and Future Plans
2.12 Guardant Health Inc.
2.12.1 Guardant Health Inc. Details
2.12.2 Guardant Health Inc. Major Business
2.12.3 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.12.4 Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Guardant Health Inc. Recent Developments and Future Plans
2.13 Myriad Genetics Inc.
2.13.1 Myriad Genetics Inc. Details
2.13.2 Myriad Genetics Inc. Major Business
2.13.3 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.13.4 Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Myriad Genetics Inc. Recent Developments and Future Plans
2.14 Foundation Medicine Inc.
2.14.1 Foundation Medicine Inc. Details
2.14.2 Foundation Medicine Inc. Major Business
2.14.3 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.14.4 Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Foundation Medicine Inc. Recent Developments and Future Plans
2.15 Amoy Diagnostics Co. Ltd.
2.15.1 Amoy Diagnostics Co. Ltd. Details
2.15.2 Amoy Diagnostics Co. Ltd. Major Business
2.15.3 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.15.4 Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 Amoy Diagnostics Co. Ltd. Recent Developments and Future Plans
2.16 Biocartis Group NV
2.16.1 Biocartis Group NV Details
2.16.2 Biocartis Group NV Major Business
2.16.3 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product and Solutions
2.16.4 Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Biocartis Group NV Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Liquid Biopsy For Cancer Diagnostics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Liquid Biopsy For Cancer Diagnostics by Company Revenue
3.2.2 Top 3 Liquid Biopsy For Cancer Diagnostics Players Market Share in 2022
3.2.3 Top 6 Liquid Biopsy For Cancer Diagnostics Players Market Share in 2022
3.3 Liquid Biopsy For Cancer Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Liquid Biopsy For Cancer Diagnostics Market: Region Footprint
3.3.2 Liquid Biopsy For Cancer Diagnostics Market: Company Product Type Footprint
3.3.3 Liquid Biopsy For Cancer Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Liquid Biopsy For Cancer Diagnostics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
5.1 Global Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Application (2018-2023)
5.2 Global Liquid Biopsy For Cancer Diagnostics Market Forecast by Application (2024-2029)
6 North America
6.1 North America Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2018-2029)
6.2 North America Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2029)
6.3 North America Liquid Biopsy For Cancer Diagnostics Market Size by Country
6.3.1 North America Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2018-2029)
6.3.2 United States Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
6.3.3 Canada Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
6.3.4 Mexico Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2018-2029)
7.2 Europe Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2029)
7.3 Europe Liquid Biopsy For Cancer Diagnostics Market Size by Country
7.3.1 Europe Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2018-2029)
7.3.2 Germany Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
7.3.3 France Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
7.3.5 Russia Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
7.3.6 Italy Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Market Size by Region
8.3.1 Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value by Region (2018-2029)
8.3.2 China Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
8.3.3 Japan Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
8.3.4 South Korea Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
8.3.5 India Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
8.3.7 Australia Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2018-2029)
9.2 South America Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2029)
9.3 South America Liquid Biopsy For Cancer Diagnostics Market Size by Country
9.3.1 South America Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2018-2029)
9.3.2 Brazil Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
9.3.3 Argentina Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Market Size by Country
10.3.1 Middle East & Africa Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2018-2029)
10.3.2 Turkey Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
10.3.4 UAE Liquid Biopsy For Cancer Diagnostics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Liquid Biopsy For Cancer Diagnostics Market Drivers
11.2 Liquid Biopsy For Cancer Diagnostics Market Restraints
11.3 Liquid Biopsy For Cancer Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Liquid Biopsy For Cancer Diagnostics Industry Chain
12.2 Liquid Biopsy For Cancer Diagnostics Upstream Analysis
12.3 Liquid Biopsy For Cancer Diagnostics Midstream Analysis
12.4 Liquid Biopsy For Cancer Diagnostics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Liquid Biopsy For Cancer Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Liquid Biopsy For Cancer Diagnostics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Liquid Biopsy For Cancer Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Liquid Biopsy For Cancer Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. F. Hoffman La Roche Ltd. Company Information, Head Office, and Major Competitors
Table 6. F. Hoffman La Roche Ltd. Major Business
Table 7. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 8. F. Hoffman La Roche Ltd. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. F. Hoffman La Roche Ltd. Recent Developments and Future Plans
Table 10. Thermo Fisher Scientific Inc. Company Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Inc. Major Business
Table 12. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 13. Thermo Fisher Scientific Inc. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Thermo Fisher Scientific Inc. Recent Developments and Future Plans
Table 15. Agilent Technologies Inc. Company Information, Head Office, and Major Competitors
Table 16. Agilent Technologies Inc. Major Business
Table 17. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 18. Agilent Technologies Inc. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Agilent Technologies Inc. Recent Developments and Future Plans
Table 20. Illumina Inc. Company Information, Head Office, and Major Competitors
Table 21. Illumina Inc. Major Business
Table 22. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 23. Illumina Inc. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Illumina Inc. Recent Developments and Future Plans
Table 25. The Menarini Group Company Information, Head Office, and Major Competitors
Table 26. The Menarini Group Major Business
Table 27. The Menarini Group Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 28. The Menarini Group Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. The Menarini Group Recent Developments and Future Plans
Table 30. Bio-Rad Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 31. Bio-Rad Laboratories Inc. Major Business
Table 32. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 33. Bio-Rad Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Bio-Rad Laboratories Inc. Recent Developments and Future Plans
Table 35. QIAGEN Inc. Company Information, Head Office, and Major Competitors
Table 36. QIAGEN Inc. Major Business
Table 37. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 38. QIAGEN Inc. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. QIAGEN Inc. Recent Developments and Future Plans
Table 40. Exact Sciences Corporation Company Information, Head Office, and Major Competitors
Table 41. Exact Sciences Corporation Major Business
Table 42. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 43. Exact Sciences Corporation Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Exact Sciences Corporation Recent Developments and Future Plans
Table 45. Bio-Techne Corporation Company Information, Head Office, and Major Competitors
Table 46. Bio-Techne Corporation Major Business
Table 47. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 48. Bio-Techne Corporation Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Bio-Techne Corporation Recent Developments and Future Plans
Table 50. ArcherDX Inc. Company Information, Head Office, and Major Competitors
Table 51. ArcherDX Inc. Major Business
Table 52. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 53. ArcherDX Inc. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. ArcherDX Inc. Recent Developments and Future Plans
Table 55. Neogenomics Laboratories Inc. Company Information, Head Office, and Major Competitors
Table 56. Neogenomics Laboratories Inc. Major Business
Table 57. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 58. Neogenomics Laboratories Inc. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Neogenomics Laboratories Inc. Recent Developments and Future Plans
Table 60. Guardant Health Inc. Company Information, Head Office, and Major Competitors
Table 61. Guardant Health Inc. Major Business
Table 62. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 63. Guardant Health Inc. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Guardant Health Inc. Recent Developments and Future Plans
Table 65. Myriad Genetics Inc. Company Information, Head Office, and Major Competitors
Table 66. Myriad Genetics Inc. Major Business
Table 67. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 68. Myriad Genetics Inc. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Myriad Genetics Inc. Recent Developments and Future Plans
Table 70. Foundation Medicine Inc. Company Information, Head Office, and Major Competitors
Table 71. Foundation Medicine Inc. Major Business
Table 72. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 73. Foundation Medicine Inc. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Foundation Medicine Inc. Recent Developments and Future Plans
Table 75. Amoy Diagnostics Co. Ltd. Company Information, Head Office, and Major Competitors
Table 76. Amoy Diagnostics Co. Ltd. Major Business
Table 77. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 78. Amoy Diagnostics Co. Ltd. Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 79. Amoy Diagnostics Co. Ltd. Recent Developments and Future Plans
Table 80. Biocartis Group NV Company Information, Head Office, and Major Competitors
Table 81. Biocartis Group NV Major Business
Table 82. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Product and Solutions
Table 83. Biocartis Group NV Liquid Biopsy For Cancer Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 84. Biocartis Group NV Recent Developments and Future Plans
Table 85. Global Liquid Biopsy For Cancer Diagnostics Revenue (USD Million) by Players (2018-2023)
Table 86. Global Liquid Biopsy For Cancer Diagnostics Revenue Share by Players (2018-2023)
Table 87. Breakdown of Liquid Biopsy For Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 88. Market Position of Players in Liquid Biopsy For Cancer Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 89. Head Office of Key Liquid Biopsy For Cancer Diagnostics Players
Table 90. Liquid Biopsy For Cancer Diagnostics Market: Company Product Type Footprint
Table 91. Liquid Biopsy For Cancer Diagnostics Market: Company Product Application Footprint
Table 92. Liquid Biopsy For Cancer Diagnostics New Market Entrants and Barriers to Market Entry
Table 93. Liquid Biopsy For Cancer Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 94. Global Liquid Biopsy For Cancer Diagnostics Consumption Value (USD Million) by Type (2018-2023)
Table 95. Global Liquid Biopsy For Cancer Diagnostics Consumption Value Share by Type (2018-2023)
Table 96. Global Liquid Biopsy For Cancer Diagnostics Consumption Value Forecast by Type (2024-2029)
Table 97. Global Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2023)
Table 98. Global Liquid Biopsy For Cancer Diagnostics Consumption Value Forecast by Application (2024-2029)
Table 99. North America Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 100. North America Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 101. North America Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 102. North America Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 103. North America Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 104. North America Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 105. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 106. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 107. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 108. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 109. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 112. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 113. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 114. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 115. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 116. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 117. South America Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 118. South America Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 119. South America Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 120. South America Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 121. South America Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 122. South America Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 123. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 124. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 125. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 126. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 127. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 128. Middle East & Africa Liquid Biopsy For Cancer Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 129. Liquid Biopsy For Cancer Diagnostics Raw Material
Table 130. Key Suppliers of Liquid Biopsy For Cancer Diagnostics Raw Materials
List of Figures
Figure 1. Liquid Biopsy For Cancer Diagnostics Picture
Figure 2. Global Liquid Biopsy For Cancer Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Type in 2022
Figure 4. Blood Test
Figure 5. Urine Test
Figure 6. Saliva Test
Figure 7. Global Liquid Biopsy For Cancer Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Application in 2022
Figure 9. Hospital Picture
Figure 10. Diagnostic Center Picture
Figure 11. Others Picture
Figure 12. Global Liquid Biopsy For Cancer Diagnostics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Liquid Biopsy For Cancer Diagnostics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market Liquid Biopsy For Cancer Diagnostics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 16. Global Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Region in 2022
Figure 17. North America Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 20. South America Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 22. Global Liquid Biopsy For Cancer Diagnostics Revenue Share by Players in 2022
Figure 23. Liquid Biopsy For Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players Liquid Biopsy For Cancer Diagnostics Market Share in 2022
Figure 25. Global Top 6 Players Liquid Biopsy For Cancer Diagnostics Market Share in 2022
Figure 26. Global Liquid Biopsy For Cancer Diagnostics Consumption Value Share by Type (2018-2023)
Figure 27. Global Liquid Biopsy For Cancer Diagnostics Market Share Forecast by Type (2024-2029)
Figure 28. Global Liquid Biopsy For Cancer Diagnostics Consumption Value Share by Application (2018-2023)
Figure 29. Global Liquid Biopsy For Cancer Diagnostics Market Share Forecast by Application (2024-2029)
Figure 30. North America Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 31. North America Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 32. North America Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 33. United States Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 40. France Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 47. China Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 50. India Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 53. South America Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 54. South America Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 55. South America Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa Liquid Biopsy For Cancer Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE Liquid Biopsy For Cancer Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 64. Liquid Biopsy For Cancer Diagnostics Market Drivers
Figure 65. Liquid Biopsy For Cancer Diagnostics Market Restraints
Figure 66. Liquid Biopsy For Cancer Diagnostics Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Liquid Biopsy For Cancer Diagnostics in 2022
Figure 69. Manufacturing Process Analysis of Liquid Biopsy For Cancer Diagnostics
Figure 70. Liquid Biopsy For Cancer Diagnostics Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
